Tempus AI (NASDAQ:TEM) had its price target lowered by analysts at JPMorgan Chase & Co. from $85.00 to $80.00. They now have a "neutral" rating on the stock.
Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now? [Yahoo! Finance]
Tempus Announces Ten Abstracts Accepted for Presentation at the 2025 San Antonio Breast Cancer Symposium
Tempus AI, Inc. (TEM): A Bull Case Theory [Yahoo! Finance]
Tempus AI (NASDAQ:TEM) was given a new $85.00 price target on by analysts at Morgan Stanley.